A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
01/2012
01/03/2012	CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
01/03/2012	CA2226973C Modulators of the function of fas receptors and other proteins
01/03/2012	CA2209771C Combined therapeutical treatment of hyperproliferative diseases
12/2011
12/29/2011	WO2011163492A1 Collagen-binding synthetic peptidoglycans for use in vascular intervention
12/29/2011	WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor
12/29/2011	WO2011161964A1 Agent for improving insulin resistance with acat inhibitor as active component
12/29/2011	WO2011161209A1 Injectable formulation of a macrocyclic lactone and levamisole
12/29/2011	WO2011161099A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes
12/29/2011	WO2011160823A1 Combination of d-amino acids and phenylbutyric acid
12/29/2011	WO2011160822A1 Organic salts and co-crystals of phenylbutyric acid of d-amino acids
12/29/2011	WO2011160768A1 Medical device for self-administration of patients with acute coronary events
12/29/2011	WO2011130566A3 Method for treating solid tumors
12/29/2011	WO2010129138A3 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
12/29/2011	US20110319483 1-adamantyl chalcones for the treatment of proliferative disorders
12/29/2011	US20110319327 Polypeptides Homologous to VEGF and BMP1
12/29/2011	US20110318402 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	CA2803688A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes
12/28/2011	EP2399927A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
12/28/2011	EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/28/2011	EP2399582A1 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
12/28/2011	EP2399577A1 Use of N-containing spirocompounds for the enhancement of cognitive function
12/28/2011	EP2399575A2 Methods, uses and compositions for treatment of an infection by a virus of the family of flaviviridae through the farnesoid X receptor (FXR) inhibition
12/28/2011	EP2398472A2 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
12/28/2011	EP2398458A1 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
12/28/2011	EP2398325A1 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
12/28/2011	EP2398319A1 Therapeutic compositions and methods for treating chronic kidney disease associated with a metabolic imbalance
12/28/2011	EP2070536B1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent
12/28/2011	EP1971341B1 Use of morpholino compounds for the treatment of halitosis
12/28/2011	EP1841458B1 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
12/28/2011	EP1782804B1 MEDICINAL COMPOSITION, COMPRISING A HMG-CoA REDUCTASE INHIBITOR AND AN AMINO ALCOHOL DERIVATIVE, AS IMMUNOSUPPRESSANT
12/28/2011	EP1443920B1 Preparation for improving the action of receptors
12/28/2011	EP1411918B1 Methods to mobilize progenitor/stem cells
12/28/2011	EP1316315B1 Serum thymic factor for use in the treatment of oxidative stress in allergy
12/28/2011	EP1234033B1 Methods for targeting cells that express fibroblast growth factor receptor-3 or-2
12/28/2011	CN102300567A 用于治疗儿科患者的糖尿病的dpp-iv抑制剂 Dpp-iv for the treatment of pediatric patients with diabetes inhibitor
12/28/2011	CN102294032A 含有以锌盐形式存在的他汀类药物的药用组合物 Pharmaceutical compositions containing zinc in the form of statin drugs
12/28/2011	CN102294031A 含质子泵抑制剂、nsaid和抗酸剂的药物制剂 Pharmaceutical formulation containing a proton pump inhibitor, nsaid and antacid
12/28/2011	CN102294030A 性激素在治疗类风湿关节炎的用途 Hormone in the treatment of rheumatoid arthritis use
12/28/2011	CN102293746A 治疗性脂质体 Therapeutic liposomes
12/28/2011	CN101766569B 一种长效抗菌药物油乳剂及其制备方法 A long-acting antimicrobial drugs oil emulsion and its preparation method
12/28/2011	CN101690713B 一种喹诺酮注射液的制备方法 An injection method for producing a quinolone liquid
12/28/2011	CN101336914B 一种缩小心肌梗死面积的药物组合物及其应用 Reduce myocardial infarct size of one kind of pharmaceutical compositions and applications
12/28/2011	CN101247832B 含有血管紧张素Ⅱ受体拮抗剂和钙通道阻断剂的药物制剂 Containing an angiotensin Ⅱ receptor antagonists and calcium channel blockers in pharmaceutical formulations
12/28/2011	CN101244262B 一种治疗细菌性感染的药物联合药剂 A bacterial infection of the combination drug therapy agent
12/28/2011	CN101175532B 包含一种抗寄生虫药物和一种选自香芹醇、麝香草酚、丁香酚、樟醇、香芹酚、α-紫罗兰酮或β-紫罗兰酮的活性成分的药物组合物 An antiparasitic and comprising one member selected from carveol, thymol, eugenol, camphor alcohol, carvacrol, pharmaceutical compositions α- or β- ionone ionone active ingredient
12/27/2011	US8084424 Compositions and methods related to erythropoietin
12/27/2011	US8084233 Nucleic acids encoding anti-IL-12 antibody
12/27/2011	US8084058 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
12/27/2011	US8084020 Use of anti-CD1 antibodies for the modulation of immune responses
12/22/2011	WO2011158933A1 Agent for treating renal fibrosis
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011158206A1 An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
12/22/2011	WO2011157908A1 Use of the combination of an inhibitor of the if current of the sinoatrial node and an inhibitor of the angiotensin-converting enzyme for treating heart failure
12/22/2011	WO2011157724A1 S100a4 antibodies and therapeutic uses thereof
12/22/2011	WO2011157391A1 Pharmaceutical combination for the treatment of pain
12/22/2011	WO2011133870A3 Vaccines comprising adenovirus vectors and signaling lymphocyte activating molecule-associated protein (sap)
12/22/2011	WO2011128434A3 Treatment of endocrine resistant breast cancer
12/22/2011	WO2011128407A9 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations
12/22/2011	US20110313031 Olioodeoxynucleotide and its use to induce an immune response
12/22/2011	US20110312982 Cancer Treatment Method
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110312093 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders
12/22/2011	US20110311648 Novel Methods for the Treatment of Cancer
12/22/2011	US20110311540 Wisp polypeptides and nucleic acids encoding same
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311482 Hepatitis C Virus Inhibitors
12/22/2011	DE102010034595A1 Use of an active ingredient of a histone demethylase inhibitor for treating cancer/tumors and/or neoplastic diseases, where the histone demethylase is from Jumonji/AT-rich interactive domain-containing protein family
12/22/2011	CA2802974A1 An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
12/22/2011	CA2802631A1 S100a4 antibodies and therapeutic uses thereof
12/22/2011	CA2802414A1 Agent for treating renal fibrosis
12/22/2011	CA2796774A1 Pharmaceutical combination for the treatment of pain
12/21/2011	EP2397159A2 Combination of morphinan compounds and antidepressant for the treatment of intractable and chronic pain
12/21/2011	EP2397158A2 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect
12/21/2011	EP2397157A1 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
12/21/2011	EP2397140A1 Compositions and methods for treating or preventing glaucoma or progression thereof
12/21/2011	EP2397136A1 Anti-inflammatory composition
12/21/2011	EP2397135A1 An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
12/21/2011	EP2397128A1 Use of L-arginine optionally combined with magnesium for the treatment of sickle cell disease and/or pulmonary hypertension
12/21/2011	EP2397121A2 Pharmaceutical preparation containing Entacapone, Levodopa and Carbidopa
12/21/2011	EP2397118A1 Device for pressure bathing in gas-containing mist
12/21/2011	EP2396348A1 Methods for inducing transplantation tolerance
12/21/2011	EP2396011A2 Fibronectin type iii domain based scaffold compositions, methods and uses
12/21/2011	EP2396006A1 High dosage doramectin formulation
12/21/2011	EP2396003A2 A composition comprising (-)-trans-3-(5,6-dihydro-4h-pyrrolo [3,2,1-ij] quinolin-1-yl)-4-(1h-indol-3-yl) pyrrolidine-2, 5-dione in combination with a second anti-proliferative agent,
12/21/2011	EP2395998A1 Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases
12/21/2011	EP2395989A1 Treatment solution for treating wounds, in particular for liquid wound treatment
12/21/2011	EP2395988A2 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
12/21/2011	EP2395987A1 Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
12/21/2011	EP2395984A1 Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
12/21/2011	EP2395838A1 Stable pharmaceutical composition for atherosclerosis
12/21/2011	EP1534290B1 Novel inhibitors of kinases
12/21/2011	EP1266003B1 Kcnb: a potassium channel protein
12/21/2011	EP1229895B1 Slimming composition containing a substance inducing il-6 production
12/21/2011	CN102292111A 复合物及其制造方法 Composite and manufacturing method thereof
12/21/2011	CN102292108A 包括甲胺喋呤以及二氢乳清酸脱氢酶抑制剂的组合 Include a combination of methotrexate and methylamine DHODH inhibitors
12/21/2011	CN102292106A Il-6抗体及其用途 Il-6 antibody and uses thereof
12/21/2011	CN102284060A 窦房结I<sub>f</sub>当前抑制剂和血管紧张素转化酶抑制剂的组合在治疗心力衰竭中的用途 Sinus I <sub> f </ sub> current inhibitors and angiotensin converting enzyme inhibitors in the treatment of heart failure in combination use
12/21/2011	CN102283853A 包含二甲双胍和格列本脲组合的药用组合物 Pharmaceutical compositions containing metformin and glyburide combination
12/21/2011	CN102283805A 一种含非离子型纤维素类滴眼液的制备方法 A method for preparing a non-ionic cellulose-containing eye drops

1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 1151